Highlights in Chronic Lymphocytic Leukemia From the 2022 American Society of Clinical Oncology Annual Meeting

A Review of Selected Presentations From the ASCO Meeting • June 3-7, 2022 • Chicago, Illinois Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive Chronic […]

The Addition of Darolutamide to Androgen Deprivation Therapy and Docetaxel in a 55-Year-Old Man With Metastatic Hormone-Sensitive Prostate Cancer

Case 3 of a 3-Part Series Patient Case In November 2021, a 55-year-old man presented to his primary care physician reporting difficulties with urination. The patient […]

Cases in the Management of Polycythemia Vera: The Importance of Strict Hematocrit Control

Case 2 of a 3-Part Series Patient Case  A 68-year-old man presented with elevated levels of hemoglobin and hematocrit, as well as an elevated platelet count […]

Back to Archive